Astera Labs, Inc. (ALAB)

Credit spreads across related paper are tightening faster than equity multiples for ALAB. High likelihood of institutional multiple re-rating if cash flows hold.

On our desk, the valuation debate on ALAB is reaching a fever pitch. With the stock surging over 200% in a matter of months and trading well above consensus targets, we are seeing a massive divergence between bulls who point to a tenfold rise in chip content per system and bears pointing to heavy insider selling and lofty multiples. At over 40 times forward revenue, the market is pricing in flawless execution of the Scorpio switch ramp. If hyperscaler CapEx slows down even slightly, multiple compression could be swift and severe.

From a technical standpoint and fundamental due diligence protocol, tracking the product mix shift is non-negotiable. Management has highlighted that the Scorpio X-series switch is on track to become their largest product line, targeting a massive scale-up market. When assessing entry points during market pullbacks, analysts must verify whether volume production of the 320-lane Scorpio X successfully converts into broad, repeatable economics rather than relying solely on the near-term tailwind from Aries retimers.

Secondary debt liquidity for ALAB proxies remains highly resilient despite headline noise. Watching gross margin expansion.